The present invention relates to a topical composition that can be used to treat skin laxity, cellulite and to firm, smooth and/or tone skin.

The present invention relates to a topical composition that can be used to treat skin laxity, cellulite and to firm, smooth and/or tone skin.

The present disclosure relates to a moisturizing or anti-atopic composition, including a fatty acid or a fatty acid derivative. More specifically, the present disclosure relates to a moisturizing or anti-atopic composition including at least one compound selected from the group consisting of ethyl linoleate, α-linolenic acid, and monolinolein as an active ingredient. The composition for moisturizing or anti-atopic dermatitis, according to the present disclosure, has not only low cytotoxicity but also an anti-inflammatory effect, an increase in the amount of moisturizing factor production, an increase in the amount of skin bather strengthening factor production, and an active effect to inhibit the production of atopic factors, so it can be used in various fields such as beauty for improving skin condition, pharmaceuticals, and food.

The present disclosure relates to a moisturizing or anti-atopic composition, including a fatty acid or a fatty acid derivative. More specifically, the present disclosure relates to a moisturizing or anti-atopic composition including at least one compound selected from the group consisting of ethyl linoleate, α-linolenic acid, and monolinolein as an active ingredient. The composition for moisturizing or anti-atopic dermatitis, according to the present disclosure, has not only low cytotoxicity but also an anti-inflammatory effect, an increase in the amount of moisturizing factor production, an increase in the amount of skin bather strengthening factor production, and an active effect to inhibit the production of atopic factors, so it can be used in various fields such as beauty for improving skin condition, pharmaceuticals, and food.

The present invention relates to a cosmetic composition.

This composition is characterized in that it comprises, as active ingredient, a green extract of seeds of the Aframomum angustifolium or longoza plant, obtained by extraction with a polar solvent of polyol, in particular a glycol, optionally in a cosmetically acceptable excipient.

This cosmetic composition has a good anti-aging effect.

A wet wipe with a substrate having cellulosic fibers and a lotion is provided. The lotion may have between about 96.0% and about 99.5%, by weight of the lotion, of water. The lotion may have a preservative system having benzoic acid and/or a salt thereof, succinic acid and/or a salt thereof, and phytic acid and/or a salt thereof. The lotion may also have a surfactant, pH buffering system, and a pH of about 3.5 to about 5.

The present invention relates to an anhydrous composition for dyeing human keratin fibers, comprising at least one natural dye, at least one hydrazono and/or azo cationic synthetic direct dye and at least one compound of formula (I) in which Y represents a C.sub.1-C.sub.4 hydroxyalkyl group or a C.sub.1-C.sub.4 hydroxyalkyloxy radical, n denotes an integer ranging from 0 to 5, and X, which may be identical or different, represents a C.sub.1-C.sub.4 alkyl radical or a halogen. The invention also relates to a process for dyeing human keratin fibers using this composition.

##STR00001##

The present invention relates to a composition for dyeing human keratin fibers, comprising at least one natural dye, at least one triarylmethane synthetic direct dye and at least one compound of formula (I), in which Y represents a C.sub.1-C.sub.4 hydroxyalkyl group or a C.sub.1-C.sub.4 hydroxyalkyloxy radical, n denotes an integer ranging from 0 to 5, and X, which may be identical or different, represents a C.sub.1-C.sub.4 alkyl radical or a halogen. The invention also relates to a process for dyeing human keratin fibers using this composition.

##STR00001##

A new type of biomaterial that can be generated from pollen, methods for its production, the various uses thereof in, for example, biological, medicinal, cosmetic, nutritional and printing applications and the materials/devices that comprise this new material are provided. The biomaterial comprises microgels of sporoderm polymer complex microcapsules (SPC-MCs), produced by deproteinizing the pollen from eudicot plants, in particular of genus Baccharis, Helianthus or Camellia, by contacting it with an aqueous base solution at elevated temperatures for up to 10 hours to obtain porous SPC-MCs, and hydrolytically degrading the SPC-MCs by contacting it with an aqueous base solution for periods up to 60 days to obtain microgels of SPC-MCs.

A new type of biomaterial that can be generated from pollen, methods for its production, the various uses thereof in, for example, biological, medicinal, cosmetic, nutritional and printing applications and the materials/devices that comprise this new material are provided. The biomaterial comprises microgels of sporoderm polymer complex microcapsules (SPC-MCs), produced by deproteinizing the pollen from eudicot plants, in particular of genus Baccharis, Helianthus or Camellia, by contacting it with an aqueous base solution at elevated temperatures for up to 10 hours to obtain porous SPC-MCs, and hydrolytically degrading the SPC-MCs by contacting it with an aqueous base solution for periods up to 60 days to obtain microgels of SPC-MCs.